Digistain is a quantitative histopathology platform designed to assess the risk of recurrence in breast cancer patients following surgery
Digistain is a quantitative histopathology platform designed to assess the risk of recurrence in breast cancer patients following surgery. It provides risk stratification information to support clinical decision-making and integrates seamlessly into existing histopathology workflows.